NCT06271603View on ClinicalTrials.gov

Evaluation of the Efficiency and Economic Impact of LC-OCT (Line-field Confocal Optical Coherence Tomography) for the Diagnosis and Management of Basal Cell Carcinomas

NANot yet recruitingINTERVENTIONAL
Enrollment

704

Participants

Timeline

Start Date

February 26, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Basal Cell Carcinoma of the Skin
Interventions
DIAGNOSTIC_TEST

diagnosis based on deepLive™ LC-OCT device

Management of BCC with an initial diagnosis based on the deepLive™ device using LC-OCT technology.

DIAGNOSTIC_TEST

diagnosis based on skin biopsy

Control Arm: Standard management with an initial diagnosis based on skin biopsy

Trial Locations (1)

92100

Hôpital Ambroise Paré, Boulogne-Billancourt

Sponsors

Lead Sponsor

Damae Medical
All Listed Sponsors
lead

Damae Medical

INDUSTRY

NCT06271603 - Evaluation of the Efficiency and Economic Impact of LC-OCT (Line-field Confocal Optical Coherence Tomography) for the Diagnosis and Management of Basal Cell Carcinomas | Biotech Hunter | Biotech Hunter